Severe Hypertriglyceridemia, large lipoproteins and protection against atherosclerosis

References

• Hulley S B, Rosenman R H, Bawol R D, Brand R J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383–9
   PubMed Web of Science ®Google Scholar
• Lippel K, Tyroler H, Eder H, Gotto A, Jr, Vahouny G. Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1981; 1: 406–17
   PubMedGoogle Scholar
• Grundy S M. Hypertriglyceridemia: Mechanisms, clinical significance, and treatment. Med Clin North Am 1982; 66: 519–35
   PubMed Web of Science ®Google Scholar
• Albrink M J, Mann E B. Serum triglycerides in coronary artery disease. Arch Intern Med 1959; 103: 4–8
   Web of Science ®Google Scholar
• Carlson L A. Serum Lipids in men with myocardial infarction. Acta Med Scand 1960; 167: 399–413
   PubMedGoogle Scholar
• Goldstein J L, Hazzard W R, Schrott H G, et al. Hyperli-pidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infraction. J Clin Invest 1973; 52: 1533–43
   PubMed Web of Science ®Google Scholar
• Gotto A M, Gorry G A, Thompson J R, et al. Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 1977; 56: 875–83
   PubMed Web of Science ®Google Scholar
• Carlson L A, Böttiger L E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol: Stockholm prospective study. Lancet 1972; 1: 865–8
   PubMed Web of Science ®Google Scholar
• Carlson L A, Böttiger L E. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm prospective study. Acta Med Scand 1985; 218: 207–11
   PubMed Web of Science ®Google Scholar
• Kannel W B, Castelli W P, Gordon T, McNamara P M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham study. Ann Intern Med 1971; 74: 1–12
   PubMed Web of Science ®Google Scholar
• Kannel W B, Castelli W P, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85–91
   PubMed Web of Science ®Google Scholar
• Duff G L, McMillan G C. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. I. The inhibition of experimental cholesterol atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis. J Exp Med 1949; 89: 611–30
   PubMed Web of Science ®Google Scholar
• McGill H C, Jr, Holman R L. The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit. Proc Soc Exp Biol Med 1949; 72: 72–5
   PubMed Web of Science ®Google Scholar
• Duff G L, Payne T PB. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. III. The mechanism of the inhibition of experimental cholesterol atherosclerosis in alloxan-diabetic rabbits. J Exp Med 1950; 92: 299–317
   PubMed Web of Science ®Google Scholar
• Pierce F T, Jr. The relationship of serum lipoproteins to atherosclerosis in the cholesterol-fed alloxanized rabbit. Circulation 1952; 5: 401–7
   PubMed Web of Science ®Google Scholar
• Cook D L, Milles L M, Green D M. The mechanism of alloxan protection in experimental atherosclerosis. J Exp Med 1954; 99: 119–24
   PubMed Web of Science ®Google Scholar
• Duff G L, Brechin D JH, Finkelstein W E. The effect of alloxan diabetes on experimental cholesterol athero-sclerosis'sin the rabbit. IV: The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. J Exp Med 1954; 100: 371–80
   PubMed Web of Science ®Google Scholar
• Kloeze J, Abdellatif A MM. Effect of palm-kernel oil and sunflower-seed oil on serum lipids and atherogenesis in alloxan diabetic rabbits. Atherosclerosis 1975; 22: 349–68
   PubMed Web of Science ®Google Scholar
• Brecher P, Chobanian A V, Small D M, et al. Relationship of an abnormal plasma lipoprotein to protection from atherosclerosis in the cholesterol-fed diabetic rabbit. J Clin Invest 1983; 72: 1553–62
   PubMed Web of Science ®Google Scholar
• Miller R A, Wilson R B. Atherosclerosis and myocardial ischemic lesions in alloxan-diabetic rabbits fed a low cholesterol diet. Arteriosclerosis 1984; 4: 586–91
   PubMedGoogle Scholar
• Dole V P, Hamlin J T. III. Particulate fat in lymph and blood. Physiol Rev 1962; 42: 674–701
   PubMed Web of Science ®Google Scholar
• Van Sickle W A, Brecher P, Aspen A, Chobanian A V. Effect of fasting on the composition of plasma lipoproteins in cholesterol-fed diabetic rabbits. J Lipid Res 1985; 26: 442–50
   PubMed Web of Science ®Google Scholar
• Stender S, Zilversmit D B. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits: Molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis 1981; 1: 38–49
   PubMedGoogle Scholar
• Stender S, Zilversmit D B. Comparison of cholesteryl ester transfer from chylomicrons and other plasma lipoproteins to aortic intima media of cholesterol-fed rabbits. Arteriosclerosis 1982; 2: 493–99
   PubMedGoogle Scholar
• Nordestgaard B G, Stender S, Kjeldsen K. Increased size of lipoproteins and reduced aortic cholesterol permeability in atherosclerosis protected alloxan-diabetic rabbits. Arteriosclerosis 1986; 6: 554, Abstract
   Google Scholar
• Kellner A, Correll J W, Ladd A T. Sustained hyperlipide-mia induced in rabbits by means of intravenously injected surface-active agents. J Exp Med 1951; 93: 373–83
   PubMed Web of Science ®Google Scholar
• Gordon D, Kobernick S D, McMillan G C, Duff G L. The effect of cortisone on the serum lipids and on the development of experimental cholesterol atherosclerosis in the rabbit. J Exp Med 1954; 88: 371–86
   Web of Science ®Google Scholar
• Kellner A, Correll J W, Ladd A T. The influence of intravenously administered surface-active agents on the de-velopemt of experimental atherosclerosis in rabbits. J Exp Med 1951; 93: 385–98
   PubMed Web of Science ®Google Scholar
• Payne T PB, Duff G L. Effect of Tween 80 on the serum lipids and the tissues of cholesterol-fed rabbits. Arch Path 1951; 51: 379–86
   Google Scholar
• Weigensberg B I. Effect of four variations of a surfactant polymer on experimental atherosclerosis in rabbits. J Atherscler Res 1969; 10: 291–301
   PubMedGoogle Scholar
• Friedman M, Byers S, George S S. Cortisone and experimental atherosclerosis. Effects upon administration. Arch Path 1964; 77: 142–58
   PubMedGoogle Scholar
• Nikkilä E A. Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. The metabolic basis of inherited disease. 5th ed, J B Stan-Bury, J B Wyngaarden, D S Fredrickson, J L Goldstein, M S Brown. McGraw-Hill, New York 1983; 6: 22–42
   Google Scholar
• Brunzell J D, Miller N E, Alaupovic P, et al. Familial chy-lomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res 1983; 24: 12–19
   PubMed Web of Science ®Google Scholar
• Havel R J, Gordon R S, Jr. Idiopathic hyperlipemia: Metabolic studies in an affected family. J Clin Invest 1960; 39: 1777–90
   PubMed Web of Science ®Google Scholar
• Fellin R, Baggio G, Poli A, et al. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives. Atherosclerosis 1983; 49: 55–68
   PubMed Web of Science ®Google Scholar
• Cox D W, Breckenridge W C, Little J A. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 1978; 299: 1421–4
   PubMed Web of Science ®Google Scholar
• Yamamura T, Sudo H, Ishikawa K, Yamamoto A. Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. Atherosclerosis 1979; 34: 53–65
   PubMed Web of Science ®Google Scholar
• Beaumont J L, Carlson L A, Cooper G R, et al. Classification of hyperlipidemias and hyperlipoproteinemias. Bull WHO 1970; 43: 891–908
   PubMed Web of Science ®Google Scholar
• Hoeg J M, Osborne J C, Gregg R E, Brewer H B. Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man. Am J Med 1983; 75: 889–92
   PubMed Web of Science ®Google Scholar
• Breckenridge W C, Little J A, Steiner G, et al. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 1978; 298: 1265–73
   PubMed Web of Science ®Google Scholar
• Suka K, Cedres C, McDonald B, et al. C-II anapolipo-proteinemia and severe hypertriglyceridemia. Report of a rare case with abscence of C-II apolipoprotein iso-forms and review of the literature. Am J Med 1984; 77: 457–62
   PubMed Web of Science ®Google Scholar
• Goldstein J L, Schrott H G, Hazzard W R, et al. Hyperli-pidemia in cornary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544–68
   PubMed Web of Science ®Google Scholar
• Brunzell J D, Albers J J, Chait A, et al. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983; 24: 147–55
   PubMed Web of Science ®Google Scholar
• Brunzell J D, Schrott H G, Motulsky A G, Bierman E L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976; 25: 313–20
   PubMed Web of Science ®Google Scholar
• Tuller E F, Mann G V, Schertenlieb F, et al. The effects of diabetic acidosis and coma upon the serum lipoproteins and cholesterol. Diabetis 1954; 3: 279–85
   PubMed Web of Science ®Google Scholar
• Kolb F O, De Lalla O F, Gofman J W. The hyperlipemias in disorders of carbohydrate metabolism: Serial lipoprotein studies in diabetic acidosis with xanthomatosis and in glycogen stroage disease. Metabolism 1955; 4: 310–7
   PubMed Web of Science ®Google Scholar
• Weidman S W, Ragland J B, Fisher J N, Jr, et al. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: Evidence for a change in high density lipoprotein composition during treatment. J Lipid Res 1982; 23: 171–82
   PubMed Web of Science ®Google Scholar